Richard D. Peterson
Director/Board Member chez UNIVERSAL INSURANCE HOLDINGS, INC.
Fortune : 418 409 $ au 31/03/2024
Profil
Richard D.
Peterson is currently an Independent Director at Universal Insurance Holdings, Inc. He is also a Member at The Financial Executives Institute and the Chief Financial Officer at Turn Biotechnologies, Inc. Mr. Peterson previously worked as the Director at The Arizona Center For Nature Conservation.
He was also the Chief Financial Officer, Treasurer & Executive VP at Medicis Pharmaceutical Corp.
from 2011 to 2012.
Before that, he worked as a Senior Financial Auditor at PricewaterhouseCoopers LLP from 1992 to 1995.
Mr. Peterson has also served as the Chief Financial Officer at Clarus Therapeutics, Inc., NVN Liquidation, Inc., Botanix Pharmaceuticals Ltd., Sienna Biopharmaceuticals, Inc., Dermavant Sciences, Inc., and Clarus Therapeutics Holdings, Inc. He completed his undergraduate degree from Arizona State University in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/06/2023 | 20 591 ( 0,07% ) | 418 409 $ | 31/03/2024 |
Postes actifs de Richard D. Peterson
| Sociétés | Poste | Début |
|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Director/Board Member | 05/06/2014 |
| The Financial Executives Institute | Corporate Officer/Principal | 26/05/2009 |
Anciens postes connus de Richard D. Peterson
| Sociétés | Poste | Fin |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Director of Finance/CFO | 31/08/2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Director of Finance/CFO | 01/05/2020 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Director of Finance/CFO | 01/02/2019 |
| SIENNA BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 29/03/2018 |
| NVN LIQUIDATION, INC. | Director of Finance/CFO | 23/03/2017 |
Formation de Richard D. Peterson
| Arizona State University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Finance |
| NVN LIQUIDATION, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
| The Financial Executives Institute | |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
